[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][N:11](C(OC(C)(C)C)=O)[CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:29])[CH2:25][O:26][CH2:27][CH3:28])=[CH:4][C:3]=1[F:30].C(OCC)(=O)C.Cl>>[ClH:1].[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][NH:11][CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:29])[CH2:25][O:26][CH2:27][CH3:28])=[CH:4][C:3]=1[F:30]To tert-butyl (6R,7R)-7-(4-chloro-3-fluorophenyl)-6-{[(ethoxyacetyl)amino]methyl}-1,4-oxazepane-4-carboxylate (125 mg) was added 4.0 M hydrogen chloride-ethyl acetate solution (2.11 ml), and the mixture was stirred at room temperature for 1 hr. The residue obtained by concentration under reduced pressure was recrystallized from ethanol-diisopropyl ether to give the title compound (92.0 mg).